INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF"

GENEVA, Aug. 11 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/051042) for "GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF" on Jan 30, 2025. With publication no. WO/2025/163561, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEBOYACE, Kevin Francis (c/o Pfizer Inc.445 Eastern Point Road, Building 98Groton, Connecticut 06340), FILIPSKI, Kevin James (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), GUAN, Yanfei ...